🔗 Permalink

Inventor profile of:

Francesca D'Addio

City:

Milan

Country:

Italy

Published Applications:

Last publication date:

2026-04-30

Top Assignees for applications by Francesca D'Addio

The entities that hold a legal rights for patent applications filed by inventor D'Addio Francesca:

Ospedale San Raffaele S.R.L. 3 Milan, Italy
ENTHERA S.R.L. 2 Milan, Italy
Nephris SrL 1 Milan, Italy

Recent patent applications by D'Addio Francesca

Francesca D'Addio from Milan, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-30

US20260116984A1

Chemistry; metallurgy

TMEM219 ANTIBODIES AND THERAPEUTIC USES THEREOF

#2 | 2025-11-13

US20250346656A1

Chemistry; metallurgy

METHODS FOR TREATING DIABETIC KIDNEY DISEASE AND GLOMERULAR DISEASE

#3 | 2025-08-28

US20250270306A1

Chemistry; metallurgy

ANTIBODIES AND USES THEREOF

#4 | 2024-11-07

US20240368290A1

Chemistry; metallurgy

TMEM219 antibodies and therapeutic uses thereof

#5 | 2023-08-03

US20230242649A1

Chemistry; metallurgy

TMEM219 ANTIBODIES AND THERAPEUTIC USES THEREOF

#6 | 2023-02-09

US20230039165A1

Chemistry; metallurgy

IGFBP3 ANTIBODIES AND THERAPEUTIC USES THEREOF

#7 | 2021-12-16

US20210388072A1

Chemistry; metallurgy

Antibodies and uses thereof

#8 | 2021-06-10

US20210169973A1

Human necessities

Inhibitor of IGFBP3/TMEM219 Axis and Diabetes

#9 | 2020-10-08

US20200316168A1

Human necessities

INHIBITORS OF IGFBP3 BINDING TO TMEM219 FOR TREATMENT OF INTESTINAL DISEASES

#10 | 2018-08-30

US20180243367A1

Human necessities

Inhibitor of IGFBP3/TMEM219 axis and diabetes

#11 | 2018-06-21

US20180172708A1

Physics

Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases

#12 | 2018-06-21

US20180169184A1

Human necessities

Inhibitor of IGFBP3/TMEM219 Axis and Diabetes

InventorID:

2218172 ⎘